Ultra-processed foods (UPFs) account for a significant portion of energy intake in Western countries—in the United States, an estimated more than half. Given this ubiquity and a growing number of observational studies linking high UPF consumption to cardiometabolic diseases, the American Heart Association (AHA) issued its first comprehensive statement on the matter in 2025 in the form of a Science Advisory. The tone is noteworthy: The AHA carefully evaluates the evidence, warns against overinterpretation, and deliberately refrains from making blanket recommendations. For cardiologists and primary care physicians, it is worthwhile to understand this nuanced stance—precisely because the issue is often sensationalized in public discourse.
Autoren
- Jens Dehn
Publikation
- CARDIOVASC
Related Topics
You May Also Like
- The Brain and the Motivation to Eat
Why is it so hard to lose weight?
- Cardiology and Nutrition
Ultra-Processed Foods and Cardiovascular Risk—The New AHA Position Statement
- Breast (HR+) and Endometrial Cancer
A Comparison of Hormone-Dependent Female Tumors
- Chronic Urticaria: Treatment for Patients Unresponsive to Antihistamines
In addition to anti-IgE antibodies, the guideline recommends anti-IL-4α antibodies and BTK inhibition
- Type 1 Diabetes in Childhood
Early Impairment of Glucagon Counterregulation
- Psychosis in Parkinson's Disease
Be Careful When Choosing Medications
- Esophageal Cancer
A Comparison of Endoscopic and Surgical Innovations
- PMR and LVV: Current EULAR Recommendations